Sponsored talks

botiss_logo.png

Dr Arturo Robertazzi

Dr Robertazzi is an experienced researcher in chemistry, biochemistry and biophysics. During his PhD program at the University of Cardiff (UK), he extensively studied the relationship between anti-cancer drugs and biological macromolecules, focusing on the interaction between DNA and experimental platinum-based drugs. He continued his scientific research in three different countries and Academic Institutions, working on systems of biological relevance. During his scientific carrier, Dr Robertazzi published more than 30 articles in international high-level scientific journals; is the co-author of three books; has participated as a speaker at several conferences. As Deputy Director of Global Sales Education, Dr Robertazzi leads the botiss team, whose aim is to
develop scientific/clinical collaborations and strengthen the cooperation with distribution partners around the globe. Dr Robertazzi and his team collaborate with internationally renowned clinicians and researchers, regularly hold lectures in several countries/languages about bone and tissue regeneration, evaluate/coordinate research projects, and support the organization of international
events and congresses.

botiss biomaterials: 360° World of Regeneration

The products of the botiss regeneration system have proven their success in a multitude of
preclinical and clinical studies and, perhaps most importantly, in the daily clinical work, with
hundreds of thousands of patients treated worldwide.
During this lecture, a detailed overview of the botiss portfolio is presented along with a discussion of
the scientific/clinical evidence that demonstrates the safety, efficacy and reliability of the botiss
biomaterials portfolio. A focus will be put onto the “star products“ such as cerabone®, mucoderm®
and Jason® membrane.


Objectives of the lecture:
- To obtain detailed information about the botiss biomaterials portfolio
- To discuss scientific/clinical literature proving the top quality of products
- To acquire sufficient knowledge in order to choose the ideal botiss product combination for specific clinical       situation

- Upcoming industrial Innovation